MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx⦠read more
Healthcare
Biotechnology
9 years
USD
Exclusive to Premium users
$17.64
Price-2.11%
-$0.38
$191.846m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$19.858m
-
1y CAGR-
3y CAGR-
5y CAGR-$28.234m
-
1y CAGR-
3y CAGR-
5y CAGR-$2.64
-
1y CAGR-
3y CAGR-
5y CAGR$20.119m
$67.001m
Assets$46.882m
Liabilities$8.070m
Debt12.0%
-0.3x
Debt to EBITDA-$19.265m
-
1y CAGR-
3y CAGR-
5y CAGR